Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations.

Blood Adv · 2023 · PMC10333744 · PMID 36595486

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patient DHS17 presented an increased percentage of EVs compared with HCs, even after tretament with CaCl2 and Yoda1; in contrast, patient DHS18 only showed a trend of increased EVs levels, although not statistically significant ( Figure 3 A-B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.